Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size, Status and Forecast 2024-2031

Report ID: 934249 | Published Date: Jan 2025 | No. of Page: 96 | Base Year: 2024 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Lung Cancer
        1.2.3 Colorectal Cancer
        1.2.4 Breast Cancer
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospital
        1.3.3 Research Institutes and Research Institutions
        1.3.4 Clinic
        1.3.5 Other
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Perspective (2016-2027)
    2.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Growth Trends by Regions
        2.2.1 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Historic Market Share by Regions (2016-2021)
        2.2.3 Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecasted Market Size by Regions (2022-2027)
    2.3 Epidermal Growth Factor Receptor (EGFR) Inhibitor Industry Dynamic
        2.3.1 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Trends
        2.3.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Drivers
        2.3.3 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Challenges
        2.3.4 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Epidermal Growth Factor Receptor (EGFR) Inhibitor Players by Revenue
        3.1.1 Global Top Epidermal Growth Factor Receptor (EGFR) Inhibitor Players by Revenue (2016-2021)
        3.1.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Share by Players (2016-2021)
    3.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue
    3.4 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Concentration Ratio
        3.4.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue in 2020
    3.5 Epidermal Growth Factor Receptor (EGFR) Inhibitor Key Players Head office and Area Served
    3.6 Key Players Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Solution and Service
    3.7 Date of Enter into Epidermal Growth Factor Receptor (EGFR) Inhibitor Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Epidermal Growth Factor Receptor (EGFR) Inhibitor Breakdown Data by Type
    4.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Historic Market Size by Type (2016-2021)
    4.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecasted Market Size by Type (2022-2027)

5 Epidermal Growth Factor Receptor (EGFR) Inhibitor Breakdown Data by Application
    5.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Historic Market Size by Application (2016-2021)
    5.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2016-2027)
    6.2 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type
        6.2.1 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2016-2021)
        6.2.2 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2022-2027)
        6.2.3 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2016-2027)
    6.3 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application
        6.3.1 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2016-2021)
        6.3.2 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2022-2027)
        6.3.3 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2016-2027)
    6.4 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country
        6.4.1 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2016-2021)
        6.4.2 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2016-2027)
    7.2 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type
        7.2.1 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2016-2021)
        7.2.2 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2022-2027)
        7.2.3 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2016-2027)
    7.3 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application
        7.3.1 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2016-2021)
        7.3.2 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2022-2027)
        7.3.3 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2016-2027)
    7.4 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country
        7.4.1 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2016-2021)
        7.4.2 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2016-2027)
    8.2 Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type
        8.2.1 Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2016-2027)
    8.3 Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application
        8.3.1 Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2016-2027)
    8.4 Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Region
        8.4.1 Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2016-2027)
    9.2 Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type
        9.2.1 Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2016-2021)
        9.2.2 Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2022-2027)
        9.2.3 Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2016-2027)
    9.3 Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application
        9.3.1 Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2016-2021)
        9.3.2 Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2022-2027)
        9.3.3 Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2016-2027)
    9.4 Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country
        9.4.1 Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2016-2021)
        9.4.2 Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2016-2027)
    10.2 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type
        10.2.1 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2016-2027)
    10.3 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application
        10.3.1 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2016-2027)
    10.4 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country
        10.4.1 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Amgen Inc.
        11.1.1 Amgen Inc. Company Details
        11.1.2 Amgen Inc. Business Overview
        11.1.3 Amgen Inc. Epidermal Growth Factor Receptor (EGFR) Inhibitor Introduction
        11.1.4 Amgen Inc. Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2016-2021)
        11.1.5 Amgen Inc. Recent Development
    11.2 AstraZeneca Plc
        11.2.1 AstraZeneca Plc Company Details
        11.2.2 AstraZeneca Plc Business Overview
        11.2.3 AstraZeneca Plc Epidermal Growth Factor Receptor (EGFR) Inhibitor Introduction
        11.2.4 AstraZeneca Plc Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2016-2021)
        11.2.5 AstraZeneca Plc Recent Development
    11.3 Eli Lilly and Co.
        11.3.1 Eli Lilly and Co. Company Details
        11.3.2 Eli Lilly and Co. Business Overview
        11.3.3 Eli Lilly and Co. Epidermal Growth Factor Receptor (EGFR) Inhibitor Introduction
        11.3.4 Eli Lilly and Co. Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2016-2021)
        11.3.5 Eli Lilly and Co. Recent Development
    11.4 F. Hoffmann-La Roche Ltd.
        11.4.1 F. Hoffmann-La Roche Ltd. Company Details
        11.4.2 F. Hoffmann-La Roche Ltd. Business Overview
        11.4.3 F. Hoffmann-La Roche Ltd. Epidermal Growth Factor Receptor (EGFR) Inhibitor Introduction
        11.4.4 F. Hoffmann-La Roche Ltd. Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2016-2021)
        11.4.5 F. Hoffmann-La Roche Ltd. Recent Development
    11.5 Novartis AG
        11.5.1 Novartis AG Company Details
        11.5.2 Novartis AG Business Overview
        11.5.3 Novartis AG Epidermal Growth Factor Receptor (EGFR) Inhibitor Introduction
        11.5.4 Novartis AG Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2016-2021)
        11.5.5 Novartis AG Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Lung Cancer
    Table 3. Key Players of Colorectal Cancer
    Table 4. Key Players of Breast Cancer
    Table 5. Key Players of Others
    Table 6. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Regions (2016-2021) & (US$ Million)
    Table 9. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Regions (2016-2021)
    Table 10. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 11. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Regions (2022-2027)
    Table 12. Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Trends
    Table 13. Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Drivers
    Table 14. Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Challenges
    Table 15. Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Restraints
    Table 16. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue by Players (2016-2021) & (US$ Million)
    Table 17. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Players (2016-2021)
    Table 18. Global Top Epidermal Growth Factor Receptor (EGFR) Inhibitor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor as of 2020)
    Table 19. Ranking of Global Top Epidermal Growth Factor Receptor (EGFR) Inhibitor Companies by Revenue (US$ Million) in 2020
    Table 20. Global 5 Largest Players Market Share by Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue (CR5 and HHI) & (2016-2021)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Solution and Service
    Table 23. Date of Enter into Epidermal Growth Factor Receptor (EGFR) Inhibitor Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2016-2021) (US$ Million)
    Table 26. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Share by Type (2016-2021)
    Table 27. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 28. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 29. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Share by Application (2016-2021) & (US$ Million)
    Table 30. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Share by Application (2016-2021)
    Table 31. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 32. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 33. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2016-2021) (US$ Million)
    Table 34. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2022-2027) & (US$ Million)
    Table 35. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2016-2021) (US$ Million)
    Table 36. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2022-2027) & (US$ Million)
    Table 37. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2016-2021) & (US$ Million) 
    Table 38. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2022-2027) & (US$ Million) 
    Table 39. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2016-2021) (US$ Million)
    Table 40. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2022-2027) & (US$ Million)
    Table 41. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2016-2021) (US$ Million)
    Table 42. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2022-2027) & (US$ Million)
    Table 43. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2016-2021) & (US$ Million) 
    Table 44. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2022-2027) & (US$ Million) 
    Table 45. Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2016-2021) (US$ Million)
    Table 48. Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Region (2016-2021) & (US$ Million) 
    Table 50. Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Region (2022-2027) & (US$ Million) 
    Table 51. Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2016-2021) (US$ Million)
    Table 52. Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2022-2027) & (US$ Million)
    Table 53. Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2016-2021) (US$ Million)
    Table 54. Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2022-2027) & (US$ Million)
    Table 55. Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2016-2021) & (US$ Million) 
    Table 56. Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2022-2027) & (US$ Million) 
    Table 57. Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2016-2021) (US$ Million)
    Table 60. Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2016-2021) & (US$ Million) 
    Table 62. Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2022-2027) & (US$ Million) 
    Table 63. Amgen Inc. Company Details
    Table 64. Amgen Inc. Business Overview
    Table 65. Amgen Inc. Epidermal Growth Factor Receptor (EGFR) Inhibitor Product
    Table 66. Amgen Inc. Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2016-2021) & (US$ Million)
    Table 67. Amgen Inc. Recent Development
    Table 68. AstraZeneca Plc Company Details
    Table 69. AstraZeneca Plc Business Overview
    Table 70. AstraZeneca Plc Epidermal Growth Factor Receptor (EGFR) Inhibitor Product
    Table 71. AstraZeneca Plc Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2016-2021) & (US$ Million)
    Table 72. AstraZeneca Plc Recent Development
    Table 73. Eli Lilly and Co. Company Details
    Table 74. Eli Lilly and Co. Business Overview
    Table 75. Eli Lilly and Co. Epidermal Growth Factor Receptor (EGFR) Inhibitor Product
    Table 76. Eli Lilly and Co. Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2016-2021) & (US$ Million)
    Table 77. Eli Lilly and Co. Recent Development
    Table 78. F. Hoffmann-La Roche Ltd. Company Details
    Table 79. F. Hoffmann-La Roche Ltd. Business Overview
    Table 80. F. Hoffmann-La Roche Ltd. Epidermal Growth Factor Receptor (EGFR) Inhibitor Product
    Table 81. F. Hoffmann-La Roche Ltd. Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2016-2021) & (US$ Million)
    Table 82. F. Hoffmann-La Roche Ltd. Recent Development
    Table 83. Novartis AG Company Details
    Table 84. Novartis AG Business Overview
    Table 85. Novartis AG Epidermal Growth Factor Receptor (EGFR) Inhibitor Product
    Table 86. Novartis AG Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2016-2021) & (US$ Million)
    Table 87. Novartis AG Recent Development
    Table 88. Research Programs/Design for This Report
    Table 89. Key Data Information from Secondary Sources
    Table 90. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Type: 2020 VS 2027
    Figure 2. Lung Cancer Features
    Figure 3. Colorectal Cancer Features
    Figure 4. Breast Cancer Features
    Figure 5. Others Features
    Figure 6. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Application: 2020 VS 2027
    Figure 7. Hospital Case Studies
    Figure 8. Research Institutes and Research Institutions Case Studies
    Figure 9. Clinic Case Studies
    Figure 10. Other Case Studies
    Figure 11. Epidermal Growth Factor Receptor (EGFR) Inhibitor Report Years Considered
    Figure 12. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 13. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 14. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Regions: 2020 VS 2027
    Figure 15. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Regions (2022-2027)
    Figure 16. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Players in 2020
    Figure 17. Global Top Epidermal Growth Factor Receptor (EGFR) Inhibitor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor as of 2020
    Figure 18. The Top 10 and 5 Players Market Share by Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue in 2020
    Figure 19. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Share by Type (2016-2021)
    Figure 20. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Share by Type (2022-2027)
    Figure 21. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 22. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Type (2016-2027)
    Figure 23. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Application (2016-2027)
    Figure 24. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Country (2016-2027)
    Figure 25. United States Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Canada Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Type (2016-2027)
    Figure 29. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Application (2016-2027)
    Figure 30. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Country (2016-2027)
    Figure 31. Germany Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. France Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. U.K. Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Italy Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Russia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Nordic Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Type (2016-2027)
    Figure 39. Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Application (2016-2027)
    Figure 40. Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Region (2016-2027)
    Figure 41. China Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Japan Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. South Korea Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Southeast Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. India Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Australia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Type (2016-2027)
    Figure 49. Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Application (2016-2027)
    Figure 50. Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Country (2016-2027)
    Figure 51. Mexico Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Brazil Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Type (2016-2027)
    Figure 55. Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Application (2016-2027)
    Figure 56. Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Country (2016-2027)
    Figure 57. Turkey Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Saudi Arabia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. UAE Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. Amgen Inc. Revenue Growth Rate in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2016-2021)
    Figure 61. AstraZeneca Plc Revenue Growth Rate in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2016-2021)
    Figure 62. Eli Lilly and Co. Revenue Growth Rate in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2016-2021)
    Figure 63. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2016-2021)
    Figure 64. Novartis AG Revenue Growth Rate in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2016-2021)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Amgen Inc.
AstraZeneca Plc
Eli Lilly and Co.
F. Hoffmann-La Roche Ltd.
Novartis AG
Frequently Asked Questions
Epidermal Growth Factor Receptor (EGFR) Inhibitor report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Epidermal Growth Factor Receptor (EGFR) Inhibitor report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Epidermal Growth Factor Receptor (EGFR) Inhibitor report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Solar Home System

Solar home systems (SHS) are stand-alone photovoltaic systems that offer a cost-effective mode of ... Read More

Orthopaedic Appliances

Orthopaedic Appliances are medical devices designed to solve musculoskeletal problems. Read More

Gene Editing Tools

Gene editing (or genome editing) is the insertion, deletion or replacement of DNA at a specific s ... Read More